Cargando…

262. Pediatric Antibiotic Use in the Duke Antimicrobial Stewardship Outreach Network

BACKGROUND: The Duke Antimicrobial Stewardship Outreach Network (DASON) was established in 2013 to provide antimicrobial stewardship resources to community hospitals in the Southeast. Pediatric patients in community hospitals may benefit from antimicrobial stewardship program (ASP) activities. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Michael, Ashley, Elizabeth Dodds, Anderson, Deverick J, Dyer, April, Jones, Travis, Johnson, Melissa, Davis, Angelina, Moehring, Rebekah W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255359/
http://dx.doi.org/10.1093/ofid/ofy210.273
_version_ 1783373921631862784
author Smith, Michael
Ashley, Elizabeth Dodds
Anderson, Deverick J
Dyer, April
Jones, Travis
Johnson, Melissa
Davis, Angelina
Moehring, Rebekah W
author_facet Smith, Michael
Ashley, Elizabeth Dodds
Anderson, Deverick J
Dyer, April
Jones, Travis
Johnson, Melissa
Davis, Angelina
Moehring, Rebekah W
author_sort Smith, Michael
collection PubMed
description BACKGROUND: The Duke Antimicrobial Stewardship Outreach Network (DASON) was established in 2013 to provide antimicrobial stewardship resources to community hospitals in the Southeast. Pediatric patients in community hospitals may benefit from antimicrobial stewardship program (ASP) activities. METHODS: Antibacterial use (AU) was reviewed using the DASON Antimicrobial Stewardship Assessment Portal, which includes filters for National Healthcare Safety Network (NHSN) unit types. We performed a retrospective review of AU in pediatric units from January 1 to December 31, 2017. AU was summarized by days of therapy (DOT) and percent of total DOT for specific unit types and agents. AU rates were reported by DOT/1,000 patient-days. RESULTS: A total of 41 pediatric units were included from the 28 hospital DASON cohort: 11 Neonatal Critical Care or Step Down Nurseries, eight Pediatric Medical/Surgical Wards, and 22 Well Baby Units. There were no pediatric (non-neonatal) critical care or oncology units. A total of 21,731 antibiotic DOT were attributable to pediatric units, accounting for 1.6% of all AU in the cohort. These include 5,585 (26%) DOT in Neonatal Critical Care (level II/III) Units, 4,898 (23%) in Pediatric Medical/Surgical Units, 3,910 (18%) in Well Baby Units, 3,307 (15%) in Neonatal Critical Care (level III) Units, 3,217 (15%) in Step Down Neonatal Nurseries (level II), and 814 (4%) in Pediatric Medical Wards. Ampicillin (7,229 DOT, 33%), gentamicin (6,320 DOT, 29%), ceftriaxone (1,750 DOT, 8%), and vancomycin (1,462, 7%) were the most common antibiotics administered. AU rates were 219 DOT/1,000 patient-days in children when compared with 979 in adults. Unit-specific rates ranged from 65 (Well Baby Units) to 1,081 DOT/1,000 patient-days (Pediatric Medical/Surgical Units). Rates in level II and III nurseries ranged from 302 to 697 DOT/1,000 patient-days. CONCLUSION: Pediatric patients accounted for a small proportion of AU in community hospitals. AU rates on pediatric medical/surgical units were comparable with adult units. Although rates were lower in neonatal units, these units accounted for 75% of pediatric AU. Antibiotic exposure in the neonatal period has been associated with short- and long-term outcomes, including necrotizing enterocolitis, obesity, and atopy. This population would benefit from a dedicated focus from community hospital ASPs. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6255359
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62553592018-11-28 262. Pediatric Antibiotic Use in the Duke Antimicrobial Stewardship Outreach Network Smith, Michael Ashley, Elizabeth Dodds Anderson, Deverick J Dyer, April Jones, Travis Johnson, Melissa Davis, Angelina Moehring, Rebekah W Open Forum Infect Dis Abstracts BACKGROUND: The Duke Antimicrobial Stewardship Outreach Network (DASON) was established in 2013 to provide antimicrobial stewardship resources to community hospitals in the Southeast. Pediatric patients in community hospitals may benefit from antimicrobial stewardship program (ASP) activities. METHODS: Antibacterial use (AU) was reviewed using the DASON Antimicrobial Stewardship Assessment Portal, which includes filters for National Healthcare Safety Network (NHSN) unit types. We performed a retrospective review of AU in pediatric units from January 1 to December 31, 2017. AU was summarized by days of therapy (DOT) and percent of total DOT for specific unit types and agents. AU rates were reported by DOT/1,000 patient-days. RESULTS: A total of 41 pediatric units were included from the 28 hospital DASON cohort: 11 Neonatal Critical Care or Step Down Nurseries, eight Pediatric Medical/Surgical Wards, and 22 Well Baby Units. There were no pediatric (non-neonatal) critical care or oncology units. A total of 21,731 antibiotic DOT were attributable to pediatric units, accounting for 1.6% of all AU in the cohort. These include 5,585 (26%) DOT in Neonatal Critical Care (level II/III) Units, 4,898 (23%) in Pediatric Medical/Surgical Units, 3,910 (18%) in Well Baby Units, 3,307 (15%) in Neonatal Critical Care (level III) Units, 3,217 (15%) in Step Down Neonatal Nurseries (level II), and 814 (4%) in Pediatric Medical Wards. Ampicillin (7,229 DOT, 33%), gentamicin (6,320 DOT, 29%), ceftriaxone (1,750 DOT, 8%), and vancomycin (1,462, 7%) were the most common antibiotics administered. AU rates were 219 DOT/1,000 patient-days in children when compared with 979 in adults. Unit-specific rates ranged from 65 (Well Baby Units) to 1,081 DOT/1,000 patient-days (Pediatric Medical/Surgical Units). Rates in level II and III nurseries ranged from 302 to 697 DOT/1,000 patient-days. CONCLUSION: Pediatric patients accounted for a small proportion of AU in community hospitals. AU rates on pediatric medical/surgical units were comparable with adult units. Although rates were lower in neonatal units, these units accounted for 75% of pediatric AU. Antibiotic exposure in the neonatal period has been associated with short- and long-term outcomes, including necrotizing enterocolitis, obesity, and atopy. This population would benefit from a dedicated focus from community hospital ASPs. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6255359/ http://dx.doi.org/10.1093/ofid/ofy210.273 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Smith, Michael
Ashley, Elizabeth Dodds
Anderson, Deverick J
Dyer, April
Jones, Travis
Johnson, Melissa
Davis, Angelina
Moehring, Rebekah W
262. Pediatric Antibiotic Use in the Duke Antimicrobial Stewardship Outreach Network
title 262. Pediatric Antibiotic Use in the Duke Antimicrobial Stewardship Outreach Network
title_full 262. Pediatric Antibiotic Use in the Duke Antimicrobial Stewardship Outreach Network
title_fullStr 262. Pediatric Antibiotic Use in the Duke Antimicrobial Stewardship Outreach Network
title_full_unstemmed 262. Pediatric Antibiotic Use in the Duke Antimicrobial Stewardship Outreach Network
title_short 262. Pediatric Antibiotic Use in the Duke Antimicrobial Stewardship Outreach Network
title_sort 262. pediatric antibiotic use in the duke antimicrobial stewardship outreach network
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255359/
http://dx.doi.org/10.1093/ofid/ofy210.273
work_keys_str_mv AT smithmichael 262pediatricantibioticuseinthedukeantimicrobialstewardshipoutreachnetwork
AT ashleyelizabethdodds 262pediatricantibioticuseinthedukeantimicrobialstewardshipoutreachnetwork
AT andersondeverickj 262pediatricantibioticuseinthedukeantimicrobialstewardshipoutreachnetwork
AT dyerapril 262pediatricantibioticuseinthedukeantimicrobialstewardshipoutreachnetwork
AT jonestravis 262pediatricantibioticuseinthedukeantimicrobialstewardshipoutreachnetwork
AT johnsonmelissa 262pediatricantibioticuseinthedukeantimicrobialstewardshipoutreachnetwork
AT davisangelina 262pediatricantibioticuseinthedukeantimicrobialstewardshipoutreachnetwork
AT moehringrebekahw 262pediatricantibioticuseinthedukeantimicrobialstewardshipoutreachnetwork